Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman

SAN FRANCISCO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. Visit: www.hbsslaw.com/investor-fraud/cdlx Contact the Firm Now: CDLX@hbsslaw.com 844-916-0895 Investigation Into Cardlytics, Inc. (CDLX): Cardlytics Inc. is facing scrutiny from prominent shareholder rights firm Hagens B ...